Ratings by Jefferies (Biren Amin)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/4/2021 Constellation Pharmaceuticals CNST Downgrade Hold
(Buy)
33.57
(33.70)
0.39% Details
6/2/2021 Legand Biotech Corp. LEGN Maintain Buy
(N/A)
 
 
  Details
3/18/2021 Immatics IMTX Maintain Buy
(N/A)
 
 
  Details
3/16/2021 Agenus Inc. AGEN Maintain Buy
(N/A)
 
 
  Details
3/12/2021 C4 Therapeutics CCCC Maintain Buy
(N/A)
 
 
  Details
2/17/2021 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
2/17/2021 Cortexyme Inc. CRTX Downgrade Hold
(Buy)
47.47
(47.56)
0.19% Details
2/10/2021 Kadmon Holdings KDMN Maintain Buy
(N/A)
 
 
  Details
2/10/2021 Equillium EQ Maintain Buy
(N/A)
 
 
  Details
2/2/2021 Gracell Biotechnologies Inc GRCL New Coverage Buy
(N/A)
20.72
(14.56)
-29.73% Details
1/15/2021 Bicycle Therapeutics BCYC Maintain Buy
(N/A)
 
 
  Details
1/11/2021 BioAtla Inc. BCAB New Coverage Buy
(N/A)
37.83
(39.92)
5.52% Details
12/22/2020 Humanigen HGEN New Coverage Buy
(N/A)
15.51
(20.52)
32.3% Details
12/21/2020 Zentalis Pharmaceuticals ZNTL Maintain Neutral
(N/A)
 
 
  Details
12/21/2020 IGM Biosciences IGMS Maintain Buy
(N/A)
 
 
  Details
12/21/2020 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
11/13/2020 Urovant Ltd. UROV Maintain Hold
(N/A)
 
 
  Details
11/6/2020 Regeneron Pharma REGN Maintain Buy
(N/A)
 
 
  Details
11/5/2020 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
10/27/2020 C4 Therapeutics CCCC New Coverage Buy
(N/A)
26.23
(42.11)
60.54% Details
10/19/2020 Taysha Gene Therapies TSHA New Coverage Buy
(N/A)
21.05
(20.52)
-2.52% Details
9/18/2020 Agenus Inc. AGEN Maintain Buy
(N/A)
 
 
  Details
9/14/2020 Kala Pharmaceuticals KALA Downgrade Hold
(Buy)
8.91
(6.16)
-30.86% Details
8/11/2020 Equillium EQ Maintain Buy
(N/A)
 
 
  Details
8/7/2020 CytomX Therapeutics CTMX Maintain Hold
(N/A)
 
 
  Details
8/6/2020 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
8/6/2020 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
8/4/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
7/31/2020 Immunogen Inc. IMGN Maintain Hold
(N/A)
 
 
  Details
7/24/2020 Immatics IMTX New Coverage Buy
(N/A)
11.24
(12.19)
8.45% Details
7/20/2020 Constellation Pharmaceuticals CNST New Coverage Buy
(N/A)
29.10
(33.70)
15.81% Details
7/14/2020 Forma Therapeutics FMTX New Coverage Buy
(N/A)
43.54
(24.26)
-44.28% Details
7/7/2020 Vaxcyte PCVX New Coverage Buy
(N/A)
29.38
(22.97)
-21.82% Details
7/1/2020 Legand Biotech Corp. LEGN New Coverage Buy
(N/A)
41.10
(40.44)
-1.61% Details
6/29/2020 Heron Therapeutics HRTX Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
6/2/2020 Regeneron Pharma REGN Maintain Buy
(N/A)
 
 
  Details
6/2/2020 Cortexyme Inc. CRTX New Coverage Buy
(N/A)
46.09
(47.56)
3.19% Details
6/1/2020 CytomX Therapeutics CTMX Downgrade Hold
(Buy)
8.73
(7.24)
-17.07% Details
5/29/2020 Minerva Neurosciences NERV Downgrade Hold
(Buy)
13.47
(2.96)
-78.03% Details
5/18/2020 Zentalis Pharmaceuticals ZNTL Maintain Buy
(N/A)
 
 
  Details
5/11/2020 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
5/7/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
5/5/2020 Regeneron Pharma REGN Maintain Buy
(N/A)
 
 
  Details
4/28/2020 Zentalis Pharmaceuticals ZNTL Maintain Neutral
(Buy)
 
 
  Details
3/27/2020 Calithera Biosciences CALA New Coverage Buy
(N/A)
4.20
(2.31)
-45% Details
2/25/2020 Regeneron Pharma REGN Upgrade Buy
(Hold)
403.15
(528.75)
31.15% Details
2/14/2020 Immunogen Inc. IMGN Maintain Hold
(N/A)
 
 
  Details
2/6/2020 Regeneron Pharma REGN Maintain Hold
(N/A)
 
 
  Details
2/5/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
12/19/2019 Synothorx Inc. THOR Downgrade Hold
(Buy)
67.95
(67.99)
0.06% Details
11/8/2019 AnaptysBio ANAB Downgrade Hold
(Buy)
36.16
(24.89)
-31.17% Details
10/14/2019 IGM Biosciences IGMS New Coverage Buy
(N/A)
17.43
(96.10)
451.35% Details
10/10/2019 The Medicines Company MDCO Downgrade Hold
(Buy)
50.97
(84.90)
66.57% Details
10/1/2019 Minerva Neurosciences NERV Maintain Buy
(N/A)
 
 
  Details
8/5/2019 Glycomimetics GLYC Downgrade Hold
(Buy)
9.13
(2.73)
-70.1% Details
6/17/2019 Bicycle Therapeutics BCYC New Coverage Buy
(N/A)
12.40
(29.79)
140.24% Details
5/30/2019 Heron Therapeutics HRTX Maintain Buy
(N/A)
 
 
  Details
4/17/2019 Regeneron Pharma REGN Maintain Hold
(N/A)
 
 
  Details
3/20/2019 Advaxis ADXS Maintain Hold
(N/A)
 
 
  Details
3/14/2019 Kala Pharmaceuticals KALA New Coverage Buy
(N/A)
8.21
(8.91)
8.53% Details
3/13/2019 Synothorx Inc. THOR Maintain Buy
(N/A)
 
 
  Details
3/11/2019 TCR2 Therapeutics TCRR New Coverage Buy
(N/A)
18.02
(18.07)
0.28% Details
3/1/2019 Immunogen Inc. IMGN Downgrade Hold
(Buy)
4.72
(6.59)
39.62% Details
1/2/2019 Synothorx Inc. THOR New Coverage Buy
(N/A)
17.38
(67.99)
291.2% Details
12/13/2018 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
11/6/2018 Equillium EQ New Coverage Buy
(N/A)
15.03
(5.99)
-60.15% Details
11/5/2018 Fate Therapeutics FATE New Coverage Buy
(N/A)
13.61
(85.34)
527.04% Details
11/5/2018 Allogene ALLO New Coverage Buy
(N/A)
26.95
(25.37)
-5.86% Details
10/22/2018 Urovant Ltd. UROV New Coverage Buy
(N/A)
12.19
(16.24)
33.22% Details
10/10/2018 Trevena TRVN Downgrade Hold
(Buy)
1.07
(2.20)
105.61% Details
8/24/2018 Ardelyx, Inc ARDX New Coverage Buy
(N/A)
4.20
(7.68)
82.86% Details